These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29921294)

  • 21. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Escherichia coli heat-labile enterotoxin B subunit enhances the immune response against canine parvovirus VP2 in mice immunized by VP2 DNA vaccine].
    Han D; Zhong F; Li X; Wang W; Wang X; Pan S
    Wei Sheng Wu Xue Bao; 2011 Jan; 51(1):91-7. PubMed ID: 21465794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-assembly of virus-like particles of rabbit hemorrhagic disease virus capsid protein expressed in Escherichia coli and their immunogenicity in rabbits.
    Guo H; Zhu J; Tan Y; Li C; Chen Z; Sun S; Liu G
    Antiviral Res; 2016 Jul; 131():85-91. PubMed ID: 27118636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
    Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
    J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the Assembly and Disassembly of PCV2b Virus-Like Particles Using Fluorescence Spectroscopy Analysis.
    Fang M; Diao W; Dong B; Wei H; Liu J; Hua L; Zhang M; Guo S; Xiao Y; Yu Y; Wang L; Wan M
    Intervirology; 2015; 58(5):318-23. PubMed ID: 26783743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
    Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus.
    Molina A; Veramendi J; Hervás-Stubbs S
    Virology; 2005 Nov; 342(2):266-75. PubMed ID: 16140352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
    J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No evidence for a role of modified live virus vaccines in the emergence of canine parvovirus.
    Truyen U; Geissler K; Parrish CR; Hermanns W; Siegl G
    J Gen Virol; 1998 May; 79 ( Pt 5)():1153-8. PubMed ID: 9603330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice.
    Wang C; Zheng X; Gai W; Wong G; Wang H; Jin H; Feng N; Zhao Y; Zhang W; Li N; Zhao G; Li J; Yan J; Gao Y; Hu G; Yang S; Xia X
    Antiviral Res; 2017 Apr; 140():55-61. PubMed ID: 28040513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
    Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
    Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant ELISA using baculovirus-expressed VP2 for detection of antibodies against canine parvovirus.
    Elia G; Desario C; Pezzoni G; Camero M; Brocchi E; Decaro N; Martella V; Buonavoglia C
    J Virol Methods; 2012 Sep; 184(1-2):98-102. PubMed ID: 22664182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and efficacy evaluation of remodeled canine parvovirus-like particles displaying major antigenic epitopes of a giant panda derived canine distemper virus.
    Zhao S; Han X; Lang Y; Xie Y; Yang Z; Zhao Q; Wen Y; Xia J; Wu R; Huang X; Huang Y; Cao S; Lan J; Luo L; Yan Q
    Front Microbiol; 2023; 14():1117135. PubMed ID: 36922967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Chicken IgY Generated Against Canine Parvovirus Viral-Like Particles and Development of Enzyme-Linked Immunosorbent Assay and Immunochromatographic Assay for Canine Parvovirus Detection.
    He J; Wang Y; Sun S; Zhang X
    Viral Immunol; 2015 Nov; 28(9):489-94. PubMed ID: 26469376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant canine parvovirus-like particles express foreign epitopes in silkworm pupae.
    Feng H; Liang M; Wang HL; Zhang T; Zhao PS; Shen XJ; Zhang RZ; Hu GQ; Gao YQ; Wang CY; Wang TC; Zhang W; Yang ST; Xia XZ
    Vet Microbiol; 2011 Dec; 154(1-2):49-57. PubMed ID: 21782359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles.
    Lazutka J; Simutis K; Matulis P; Petraitytė-Burneikienė R; Kučinskaitė-Kodzė I; Simanavičius M; Tamošiunas PL
    Virus Res; 2021 Jan; 292():198236. PubMed ID: 33242523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
    Cavalli A; Martella V; Desario C; Camero M; Bellacicco AL; De Palo P; Decaro N; Elia G; Buonavoglia C
    Clin Vaccine Immunol; 2008 Mar; 15(3):534-9. PubMed ID: 18160619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
    New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.